Uncategorized
Cell therapy for atrophic AMD well tolerated when delivered safely
MIAMI — Cell therapy with CNTO 2476, an adult stem cell treatment for atrophic age-related macular degeneration, is well tolerated when delivered safely into the subretinal space, a speaker told colleagues at Angiogenesis, Exudation, and Degeneration 2015.Of the 35 subjects with bilateral geographic atrophy enrolled in the study, 33 received the cells via microcatheter.